Program Objectives

1. Provide a review of new information on the basic pathophysiology of  ventricular arrhythmias
2. Provide an in-depth understanding of current management strategies used for the care of ventricular arrhythmias in various disease states, including nonpharmacological therapies such as implantable devices and catheter ablation techniques.

At the conclusion of this symposium, participants should be able to:

• Discuss strategies to improve treatment outcomes in patients with ventricular arrhythmias and structural heart disease, including new techniques and technologies
• Discuss the current status and future role of device therapy in the management of sudden cardiac death and heart failure
• Discuss the role of new techniques for VT substrate assessment, including functional scar imaging, intraprocedural MRI, and high-density mapping
• Perform risk stratification for sudden death and treatment, including VF ablation, in patients with VF due to various substrates and syndromes
• Identify the challenges related to the treatment of PVCs and idiopathic VT
• Describe the science critical to the understanding and treatment of ventricular arrhythmias, including:
  • The role of the autonomic nervous system in ventricular arrhythmogenesis
  • The anatomic substrate for ventricular tachycardia (VT)
• Describe the status of ongoing multicenter VT-related trials and discuss future directions and questions to be answered